PL3270923T3 - Środek terapeutyczny na zaburzenie czynności płata czołowego - Google Patents
Środek terapeutyczny na zaburzenie czynności płata czołowegoInfo
- Publication number
- PL3270923T3 PL3270923T3 PL16765135T PL16765135T PL3270923T3 PL 3270923 T3 PL3270923 T3 PL 3270923T3 PL 16765135 T PL16765135 T PL 16765135T PL 16765135 T PL16765135 T PL 16765135T PL 3270923 T3 PL3270923 T3 PL 3270923T3
- Authority
- PL
- Poland
- Prior art keywords
- disorder
- therapeutic agent
- frontal lobe
- lobe
- frontal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015055532 | 2015-03-19 | ||
| PCT/JP2016/059788 WO2016148308A1 (en) | 2015-03-19 | 2016-03-18 | Therapeutic agent for frontal lobe dysfunction |
| EP16765135.5A EP3270923B1 (en) | 2015-03-19 | 2016-03-18 | Therapeutic agent for frontal lobe dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3270923T3 true PL3270923T3 (pl) | 2021-12-20 |
Family
ID=56919157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16765135T PL3270923T3 (pl) | 2015-03-19 | 2016-03-18 | Środek terapeutyczny na zaburzenie czynności płata czołowego |
Country Status (38)
| Country | Link |
|---|---|
| US (2) | US20180042910A1 (pl) |
| EP (1) | EP3270923B1 (pl) |
| JP (1) | JP6869893B2 (pl) |
| KR (1) | KR20170129764A (pl) |
| CN (1) | CN107405341A (pl) |
| AR (1) | AR103972A1 (pl) |
| AU (1) | AU2016234211B2 (pl) |
| BR (1) | BR112017018165A2 (pl) |
| CA (1) | CA2978426A1 (pl) |
| CL (1) | CL2017002351A1 (pl) |
| CO (1) | CO2017008814A2 (pl) |
| CR (1) | CR20170405A (pl) |
| CY (1) | CY1124459T1 (pl) |
| DK (1) | DK3270923T3 (pl) |
| DO (1) | DOP2017000206A (pl) |
| EA (1) | EA032511B1 (pl) |
| EC (1) | ECSP17069712A (pl) |
| ES (1) | ES2884846T3 (pl) |
| GE (2) | GEAP201914604A (pl) |
| HR (1) | HRP20211340T1 (pl) |
| HU (1) | HUE055387T2 (pl) |
| IL (1) | IL254196A0 (pl) |
| JO (1) | JO3544B1 (pl) |
| LT (1) | LT3270923T (pl) |
| MX (1) | MX381277B (pl) |
| MY (1) | MY196076A (pl) |
| PE (1) | PE20171621A1 (pl) |
| PL (1) | PL3270923T3 (pl) |
| PT (1) | PT3270923T (pl) |
| RS (1) | RS62311B1 (pl) |
| SG (1) | SG11201707012YA (pl) |
| SI (1) | SI3270923T1 (pl) |
| SV (1) | SV2017005527A (pl) |
| TN (1) | TN2017000369A1 (pl) |
| TW (1) | TWI723012B (pl) |
| UA (1) | UA123578C2 (pl) |
| WO (1) | WO2016148308A1 (pl) |
| ZA (1) | ZA201706136B (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113016719B (zh) * | 2019-12-24 | 2022-08-02 | 复旦大学附属华山医院 | 一种突触核蛋白病理性快动眼睡眠行为障碍模型的制备法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69834500T2 (de) | 1997-09-05 | 2007-05-03 | Kyowa Hakko Kogyo Co., Ltd. | Xanthinderivative zur behandlung von hirnischämie |
| BRPI0418082B8 (pt) | 2003-12-26 | 2021-05-25 | Kyowa Hakko Kirin Co Ltd | derivados de tiazol úteis como antagonistas de receptor de adenosina a2a |
| EP2210891A1 (en) * | 2009-01-26 | 2010-07-28 | Domain Therapeutics | New adenosine receptor ligands and uses thereof |
| TWI548411B (zh) * | 2009-04-28 | 2016-09-11 | Kyowa Hakko Kirin Co Ltd | Exercise disorder treatment |
| UA113383C2 (xx) * | 2009-09-02 | 2017-01-25 | Терапевтичний агент для лікування тривожних розладів | |
| UA110097C2 (uk) * | 2009-09-02 | 2015-11-25 | Терапевтичний агент для лікування розладів настрою | |
| WO2012060844A1 (en) | 2010-11-05 | 2012-05-10 | Biotie Therapies, Inc | A2a antagonists as cognition and motor function enhancers |
-
2016
- 2016-03-17 JO JOP/2016/0045A patent/JO3544B1/ar active
- 2016-03-18 MY MYPI2017703320A patent/MY196076A/en unknown
- 2016-03-18 BR BR112017018165A patent/BR112017018165A2/pt not_active Application Discontinuation
- 2016-03-18 MX MX2017012020A patent/MX381277B/es unknown
- 2016-03-18 CR CR20170405A patent/CR20170405A/es unknown
- 2016-03-18 SG SG11201707012YA patent/SG11201707012YA/en unknown
- 2016-03-18 RS RS20211061A patent/RS62311B1/sr unknown
- 2016-03-18 SI SI201631316T patent/SI3270923T1/sl unknown
- 2016-03-18 EA EA201792070A patent/EA032511B1/ru unknown
- 2016-03-18 UA UAA201709985A patent/UA123578C2/uk unknown
- 2016-03-18 US US15/558,240 patent/US20180042910A1/en not_active Abandoned
- 2016-03-18 HU HUE16765135A patent/HUE055387T2/hu unknown
- 2016-03-18 HR HRP20211340TT patent/HRP20211340T1/hr unknown
- 2016-03-18 CA CA2978426A patent/CA2978426A1/en not_active Abandoned
- 2016-03-18 EP EP16765135.5A patent/EP3270923B1/en active Active
- 2016-03-18 ES ES16765135T patent/ES2884846T3/es active Active
- 2016-03-18 PT PT167651355T patent/PT3270923T/pt unknown
- 2016-03-18 PE PE2017001525A patent/PE20171621A1/es unknown
- 2016-03-18 GE GEAP201914604A patent/GEAP201914604A/en unknown
- 2016-03-18 TN TNP/2017/000369A patent/TN2017000369A1/en unknown
- 2016-03-18 AR ARP160100730A patent/AR103972A1/es unknown
- 2016-03-18 KR KR1020177026576A patent/KR20170129764A/ko not_active Withdrawn
- 2016-03-18 WO PCT/JP2016/059788 patent/WO2016148308A1/en not_active Ceased
- 2016-03-18 GE GEAP201614604A patent/GEP20197007B/en unknown
- 2016-03-18 AU AU2016234211A patent/AU2016234211B2/en not_active Ceased
- 2016-03-18 DK DK16765135.5T patent/DK3270923T3/da active
- 2016-03-18 CN CN201680012849.8A patent/CN107405341A/zh active Pending
- 2016-03-18 LT LTEP16765135.5T patent/LT3270923T/lt unknown
- 2016-03-18 TW TW105108544A patent/TWI723012B/zh not_active IP Right Cessation
- 2016-03-18 JP JP2017547186A patent/JP6869893B2/ja not_active Expired - Fee Related
- 2016-03-18 PL PL16765135T patent/PL3270923T3/pl unknown
-
2017
- 2017-08-29 IL IL254196A patent/IL254196A0/en unknown
- 2017-08-29 SV SV2017005527A patent/SV2017005527A/es unknown
- 2017-08-29 CO CONC2017/0008814A patent/CO2017008814A2/es unknown
- 2017-09-08 ZA ZA2017/06136A patent/ZA201706136B/en unknown
- 2017-09-11 DO DO2017000206A patent/DOP2017000206A/es unknown
- 2017-09-15 CL CL2017002351A patent/CL2017002351A1/es unknown
- 2017-10-18 EC ECIEPI201769712A patent/ECSP17069712A/es unknown
-
2021
- 2021-08-25 CY CY20211100762T patent/CY1124459T1/el unknown
- 2021-09-03 US US17/466,772 patent/US20210393606A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3328880T3 (da) | Terapeutiske midler | |
| EP3463464A4 (en) | ASSOCIATION TREATMENT | |
| PT3283527T (pt) | Terapêutica de combinação para o cancro | |
| EP3291824A4 (en) | ANTIMICROBIAL THERAPY | |
| LT3423103T (lt) | Pth provaistai | |
| GB201509893D0 (en) | Therapeutic agents | |
| MA39483A (fr) | Agents thérapeutiques cibles | |
| HUE050705T2 (hu) | A rákos megbetegedések kezelésére szolgáló uridin diolaxán analógjai | |
| EP3311841A4 (en) | ANTI CANCER AGENTS | |
| GB201517263D0 (en) | Therapeutic agents | |
| DK3258938T3 (da) | Phenothiazinanaloger som mitokondrie terapeutiske midler | |
| EP3307268A4 (en) | SUBSTITUTED PHENYLOXAZOLIDINONE FOR ANTIMICROBIAL THERAPY | |
| PL3259232T3 (pl) | Sposób na aerożele | |
| GB201509885D0 (en) | Therapeutic agents | |
| IL262851A (en) | Combination prime: boost therapy | |
| DK3393478T3 (da) | Kombinationsterapi | |
| EP3362091A4 (en) | COMBINATION THERAPY | |
| EP3308781A4 (en) | BLOOD PRESSURE CENTER | |
| HUE060732T2 (hu) | Terápiás szer fibrózisra | |
| GB201509888D0 (en) | Therapeutic agents | |
| EP3334447A4 (en) | CCK2R-drug conjugates | |
| EP3305294A4 (en) | AQUEOUS MEDICINE | |
| GB201513299D0 (en) | Therapeutic agents | |
| EP3349853A4 (en) | PRODRUGS OF FENCAMFAMINE | |
| LT3324951T (lt) | Peritoninis terapinis skystis |